Rare diseases
Investigational molecules
Locations
239 conditions with trials, the busiest first
357 trials across Europe, recruiting first
Study of Ivosidenib for Patients with Previously Treated Advanced or Metastatic Cholangiocarcinoma
AustriaStudy on the Safety and Effects of Resatorvid and Filgrastim for Patients with Severe Alcoholic Hepatitis and Acute-on-Chronic Liver Failure
GermanyStudy of Tenofovir Alafenamide for Children and Teens with Chronic Hepatitis B
RomaniaStudy on Durvalumab with Chemotherapy for Patients with Advanced Biliary Tract Cancer
FranceStudy on Empagliflozin for Patients with Non-Alcoholic Steatohepatitis (NASH)
CzechiaStudy on the Effectiveness and Safety of Lanifibranor for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis Stages F2/F3
BelgiumStudy of Elafibranor in Adults with Primary Biliary Cholangitis Who Don't Respond Well to or Cannot Tolerate Ursodeoxycholic Acid Treatment
CzechiaStudy of resmetirom (MGL-3196) in patients with Non-Alcoholic Steatohepatitis (NASH) to prevent liver damage and disease progression
AustriaStudy on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3
AustriaStudy on the Effectiveness of NNC0194-0499 and Semaglutide in Treating Non-Alcoholic Steatohepatitis (NASH) in Patients with Fibrosis Stages 2-4
BelgiumStudy of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab
AustriaEfficacy and Safety Evaluation of Odevixibat in Pediatric Biliary Atresia Post-Kasai Hepatoportoenterostomy: A Double-Blind, Randomized, Placebo-Controlled Trial
BelgiumThe therapies tested most often in Hepatobiliary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
